Safety and tolerability of Favipiravir compared to Ribavirin for the treatment of Lassa fever: A randomized controlled open-label phase II clinical trial
2025Journal of Interventional Epidemiology and Public HealthJournalOpen access
10.37432/jieph-confpro5-00026Full text1 citations